$150 Million is the total value of StepStone Group LP's 11 reported holdings in Q1 2013. The portfolio turnover from Q4 2012 to Q1 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2013 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FIDUS INVT CORP | 24 | Q1 2019 | 9.3% |
CAESARS ENTMT CORP | 17 | Q2 2017 | 34.3% |
QUINSTREET INC | 17 | Q3 2017 | 3.0% |
TRANSENTERIX INC | 16 | Q1 2018 | 22.6% |
NOVOCURE LTD | 14 | Q2 2019 | 36.6% |
CAESARS ACQUISITION CO | 14 | Q2 2017 | 29.6% |
WALKME LTD. | 12 | Q2 2024 | 29.4% |
ROCKET LAB USA, INC. | 12 | Q2 2024 | 18.2% |
UIPATH, INC. | 12 | Q2 2024 | 6.9% |
ROBLOX CORPORATION | 12 | Q2 2024 | 4.8% |
View StepStone Group LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NeueHealth, Inc. | February 14, 2024 | 543,776 | 6.8% |
Oblong, Inc.Sold out | February 12, 2024 | 0 | 0.0% |
Dun & Bradstreet Holdings, Inc. | February 09, 2024 | 21,239,288 | 4.8% |
MONEYLION INC. | February 10, 2023 | 24,409,821 | 9.6% |
UserTesting, Inc.Sold out | January 18, 2023 | 0 | 0.0% |
Forward Pharma A/S | December 29, 2022 | 13,709,598 | 13.8% |
Oblong, Inc. | February 11, 2022 | 3,692,661 | 12.0% |
Bright Health Group Inc. | October 08, 2021 | 44,650,937 | 7.1% |
LAUREATE EDUCATION, INC. | October 04, 2019 | 86,147,116 | 39.2% |
TRANSENTERIX INC. | February 11, 2016 | 16,607 | 0.0% |
View StepStone Group LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-11-08 |
SC 13G/A | 2024-11-08 |
40-APP | 2024-09-17 |
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-13 |
SC 13D/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
View StepStone Group LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.